Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research at AdventHealth Central Florida, Professor of Medicine at the University of Central Florida, and at Loma Linda University Health, shared a post on LinkedIn:
“Honored to receive the AdventHealth Medical Staff Excellence Research award for 2025!
This year we are taking a moment to celebrate- having more than doubled the cancer clinical trial accrual compared to last year in our Phase I new drug development program – and have co-authored numerous oral presentations, posters and papers- we are bringing novel cancer therapies to central Florida and beyond.
We still have miles to go before we sleep- thanks to support from the leadership including Rob Herzog Chris Davis Mark Socinski, collaborators in Pharma and National Cancer Institute (NCI) and our excellent team that makes it happen.”
More posts featuring Guru Sonpavde.